Skip to main content
VRXA
NASDAQ Life Sciences

VERAXA Biotech Expands R&D Hub by Over 60%, Advancing Cancer Programs Towards Clinical Development

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Healthcare
Sentiment info
Positive
Importance info
7
Price
$2.917
Mkt Cap
$92.029M
52W Low
$2.8
52W High
$27.36
52W Position info
4.2% above low
Off High info
89% below high
Rel. Volume info
12× avg
Market data snapshot near publication time

VRXA is trading near its 52-week low of $2.8 (4.2% above the low) on elevated volume (12× avg).

Summary

VERAXA Biotech has expanded its R&D hub in Heidelberg by over 60%, adding laboratory space and infrastructure. This expansion is to support planned team additions and accelerate its BiTAC-TCE and ADC cancer therapy programs towards clinical development. This follows the company's recent de-SPAC and Nasdaq listing on June 10th, and a June 18th 6-K announcing successful in vitro proof-of-concept for its BiTAC-ADC platform. For a small-cap biotech, this significant operational investment and explicit move towards clinical development for its core pipeline demonstrates execution and commitment post-listing.

At the time of this announcement, VRXA was trading at $2.92 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $92M. The 52-week trading range was $2.80 to $27.36. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

VRXA - Latest Insights

VRXA
Oct 13, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.23
Real-time Price: $0.950 info
Change: -$0.280 (-23%) info
Market Cap: $140.346M info
VRXA
Aug 10, 2026, 5:20 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $1.83
Real-time Price: $0.950 info
Change: -$0.880 (-48%) info
Market Cap: $140.346M info
VRXA
Jul 31, 2026, 5:13 PM EDT
Filing Type: F-1
Importance Score:
8
Price at Filing: $1.82
Real-time Price: $0.950 info
Change: -$0.870 (-48%) info
Market Cap: $140.346M info
VRXA
Jul 31, 2026, 5:13 PM EDT
Filing Type: F-1
Importance Score:
7
Price at Filing: $1.82
Real-time Price: $0.950 info
Change: -$0.870 (-48%) info
Market Cap: $140.346M info
VRXA
Jul 27, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.97
Real-time Price: $0.950 info
Change: -$1.02 (-52%) info
Market Cap: $140.346M info